Innovexon Nexara™

Evaluate AI technology's value and risks before you commit.

One platform for AI buyers, investors, auditors, and insurers.

Evaluate AI technology before capital is committed, risk is accepted, audits are performed, or insurance policies are issued.

Request a Demo Restricted Access Program
Built for the decision Investment Audit Underwriting Value Risk Evidence Insurability Coverage

Decide with confidence

Every evaluation produces recommendations you can confidently act on.

Innovexon Nexara translates evidence, context, and exposure into an executive decision surface — built for the seat you sit in. A preview of what each evaluation produces.

Investment

$42.8M

Projected 5-year net value · base case

Approve the pilot, but delay enterprise rollout until shared-data controls, fallback funding, and vendor terms are verified.

Projected ValueHigh
FundingPartial
ReadinessConditional

Invest, continue, or walk away

A recommendation backed by a value curve, funding posture, and the variables most likely to move the decision.

Audit

The value case held;
the containment did not.

Decision reconstruction · record verified

The exposure was identifiable from the organization's own record at go-live. An evaluation run at the time would have required verified containment before deployment.

Output reviewPartial
FallbackNot in place
MonitoringNo record

What was knowable, and when

Reconstruct a past AI decision against the evidence that existed at the time, or determine whether your AI's projected value is being realized.

Underwriting

$5.4M

Indicated premium · range $5.1M–$5.8M

Insurable with conditions. Model-change monitoring, fallback procedures, human-review coverage, and operational resilience funding remain binding conditions.

Expected loss$3.8M
Reserve$7.2M
ContainmentPartial

Insurability, priced

Translate AI exposure into premium posture, reserve support, and the conditions required before binding.

Illustrative previews. Figures and scenarios are representative, not actual client evaluations.

How Innovexon Nexara works

One platform. Multiple evaluations.

Innovexon Nexara is a patent-pending AI evaluation platform designed for AI investments and purchases, audits, and underwriting. All Innovexon Nexara evaluations are informed by the organization's industry, sector, regulatory environment, role, and decision context.

Not sure where to start? Choose Investment if you're deciding whether to adopt or buy AI, Audit if you're reviewing AI already in use, or Underwriting if you're pricing AI risk.

Investment

Confirm the AI will deliver the benefits. Flag the risks. Decide to invest, buy, continue, replace, or walk away.

Supports organizations evaluating a range of AI technologies, products, vendors, initiatives, and capital deployment decisions.

Explore Investment → Request a Demo →

Audit

Can you audit an AI decision you weren't there to witness? How will you determine if AI is delivering the ROI that led to the deployment?

Supports auditors, regulators, and teams evaluating deployed AI technologies to determine what was known, what was relied upon, what evidence existed, what was potentially foreseeable, whether projected value is being delivered, and whether the decision can be defended.

Explore Audit → Request a Demo →

Underwriting

Insure AI technology with confidence.

Supports insurers and underwriters determining whether to insure AI operational outputs based on AI-related exposure, control posture, past litigation or claims, foreseeable failure, coverage viability, and insurability.

Explore Underwriting → Request a Demo →

Why Innovexon Nexara exists

AI investment, purchasing, and use decisions are moving faster than organizations can assess the value AI may deliver and the risks it may pose to their bottom lines or people.

AI is unlocking incredible potential for businesses and organizations. Yet many leaders are learning about AI's upside and downside only after the technology has been deployed.

Innovexon Nexara was designed by a former Chief Executive and Cybersecurity Regulator who has seen the challenge of relying heavily on vendor representations without fully understanding the risks, exposure, and harm that can follow. Those gaps can leave organizations struggling to make evidence-based decisions about funding, workforce, and business.

Innovexon Nexara exists to equip business leaders to review, confirm, and decide before capital is committed or harm is propagated.

Who uses it

Innovexon Nexara was built for decision-makers, auditors, and insurers evaluating AI technology across most industries and common AI use cases.

Buyers and operators

Organizations deploying or purchasing AI technology needing to confirm the value and understand the risks before they commit.

Investors and capital decision-makers

Organizations evaluating AI investments and funding decisions involving products, vendors, companies, and initiatives.

Auditors, compliance teams, and reviewers

Teams examining AI decisions and deployments, including what was known, what was relied upon, what was potentially foreseeable, whether projected value is being delivered, and whether the decision holds up.

Insurers, underwriters, reinsurers, MGAs, and brokers

Organizations assessing AI-related exposure and coverage, including control posture, foreseeable failure, and insurability.

Strategic partners supporting qualified sectors and industries

Organizations that extend Innovexon Nexara into the decisions their clients face across qualified sectors and industries.

See Innovexon Nexara applied to a real decision.

Demonstrations are available and tailored by evaluation type, organization role, sector, and decision context — so what you see reflects the decisions your organization faces.

Request a Demo
Investment Audit Underwriting

Restricted Access

The Restricted Access Program.

Innovexon Nexara is being introduced through a guided, limited-access program for selected organizations — not open sign-up, free trials, or an open beta. Organizations interested in helping validate the platform before broader availability can learn more and express interest.

Not an open application Not free access Not an open beta Not a casual trial Not automatically granted
Explore the Restricted Access Program

Pricing

Pricing depends on the evaluation type, scope, and engagement structure.

Contact Sales

Make better decisions about AI technology.

Request a demonstration or explore whether your organization is eligible for Restricted Access.

Request a Demo Restricted Access Program